Baird analyst Jeffrey Johnson lowered the firm’s price target on Dentsply Sirona to $31 from $38 and keeps a Neutral rating on the shares. The firm said they don’t have the conviction/visibility to recommend investors step-in at current levels on this name or more broadly across most of their dental coverage. There may be a time to own dental again, but it doesn’t feel like now is that time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on XRAY:
- Dentsply Sirona announces appointment of Gladden as new board member
- Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member
- Dentsply Sirona cuts FY23 adjusted EPS view to $1.80-$1.85 from $1.92-$2.02
- Dentsply Sirona expects to repurchase $150M of common stock in Q4
- Dentsply Sirona reports Q3 adjusted EPS 49c, consensus 48c